SecBot SecBot
6-K ·Filed Oct 6, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed23d 4h ago SEC0001654954-26-008813
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine share issuance under an employee share plan with immaterial dilution. No trading action warranted; monitor for any future block listing updates or changes in share count.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+5d
GSK ▼ -0.71% at T+5d
NEUTRAL call -0.71% · α vs SPY -0.57% · entry $46.60 → $46.27
Next anchor: T+20d in 5d
Latest observation: T+13 +9.43% FF3 residual α
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
+0.90%
call +0.90% · α +1.14%
$47.02
settled 22d ago
T+5d
-0.71%
call -0.71% · α -0.57%
$46.27
settled 16d ago
T+20d
Pending
in 5d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

GSK plc filed a routine 6-K reporting the admission of 19,352 ordinary shares to trading on the London Stock Exchange under its existing Share Save Plan 2022. The new shares represent a negligible 0.00045% dilution to the total outstanding shares of 4,316,311,662. This is a standard administrative notification with no material financial or strategic impact.

Key Facts

  • 19,352 ordinary shares of 31.25 pence each were admitted to trading on the London Stock Exchange Main Market.
  • Total shares admitted to trading following this admission: 4,316,311,662.
  • Shares were issued under the existing 'GlaxoSmithKline plc Share Save Plan 2022' block listing.
  • The admission covers the period from 7 August 2026 to 2 October 2026.
  • New shares are fully fungible with existing ordinary shares (ISIN: GB00BN7SWP63).

Financial Impact

Dilution of 0.00045% of total outstanding shares; no material financial impact.

dilution

Risk Factors

  • No material risks identified from this filing.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-008813
Document: 0001654954-26-008813-index-headers.html0001654954-26-008813
Document: 0001654954-26-008813-index.html0001654954-26-008813
Document: 0001654954-26-008813.txt0001654954-26-008813
60 reports for GSK
Performance horizon
47% Hit rate @ T+5 9 of 19 directional calls Went positive at some point 15 of 21 best @ T+60▲ +9.35%Jul 17, 2026
Filters
Rows
Reports for GSK, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
6-K
NEUTRAL ★ 5/10
$49.07awaiting T+5awaiting T+5$48.31 (−1.54%)
Oct 26, 2026
3d ago
6-K
BULLISH ★ 5/10
$51.10awaiting T+5awaiting T+5$48.31 (−5.45%)
Oct 26, 2026
3d ago
6-K
NEUTRAL ★ 1/10
$51.10awaiting T+5awaiting T+5$48.31 (−5.45%)
Oct 26, 2026
3d ago
6-K
BULLISH ★ 5/10
$51.10awaiting T+5awaiting T+5$48.31 (−5.45%)
Oct 26, 2026
3d ago
6-K
NEUTRAL ★ 4/10
$51.10awaiting T+5awaiting T+5$48.31 (−5.45%)
Oct 21, 2026
8d ago
6-K
BULLISH ★ 7/10
$50.02 $50.94▲ +1.84%▲ +2.28%$48.31 (−3.41%)
Oct 19, 2026
10d ago
6-K
BULLISH ★ 7/10
$49.46 $51.10▲ +3.32%▲ +3.46%$48.31 (−2.32%)
Oct 19, 2026
10d ago
6-K
BULLISH ★ 6/10
$49.46 $51.10▲ +3.32%▲ +3.46%$48.31 (−2.32%)
Oct 15, 2026
14d ago
6-K
NEUTRAL ★ 1/10
$49.02 $51.21▲ +4.47%▲ +5.48%$48.31 (−1.44%)
Oct 14, 2026
15d ago
6-K
NEUTRAL ★ 1/10
$47.87 $50.02▲ +4.49%▲ +4.04%$48.31 (+0.93%)
Showing 10 of 60

US Market Status

Market Open · Closes in 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026